Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 5Sleep Apnea, Obstructive 2Breast Neoplasms 2Sleep Apnea Syndromes 1Osteoporosis 1Obesity 1Myocardial Ischemia 1Metabolic Syndrome 1Insulin Resistance 1Hyperandrogenism 1Heart Diseases 1Glucose Intolerance 1Estrogen Receptor Positive Breast Cancer 1Coronary Disease 1Colonic Neoplasms 1Cardiovascular Diseases 1Bone Diseases 1

Interventions

Metformin 8Progesterone 6Spironolactone 4drospirenone and ethinyl estradiol combination 3Inositol 3Ethinyl Estradiol 3salicylsalicylic acid 2Sugars 2Folic Acid 2Flutamide 2Estradiol 2Cyproterone Acetate 2Clomiphene 2maltodextrin 1licogliflozin 1bicalutamide 1Yoga 1Waist-Hip Ratio 1Waist Circumference 1Ultrasonography 1Topiramate 1Time 1Thioctic Acid 1Sodium Salicylate 1Sex Characteristics 1Physical Examination 1Phlebotomy 1Phenotype 1Ovidrel 1Magnesium 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hyperandrogenism × Estrogens × Clear all
NCT01427595 2021-01-08

Effect of Metformin on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone

University of Virginia

Phase NA Completed
25 enrolled 6 charts

Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡